Harouna Bako

Learn More
INTRODUCTION MenAfriVac is a new conjugate vaccine against Neisseria meningitidis serogroup A, the major cause of meningitis outbreaks in sub-Saharan Africa. In Niger, the MenAfriVac introduction campaign was conducted in the District of Filingue, during September 2010, targeting 392,211 individuals aged 1-29 years. We set up an enhanced spontaneous(More)
OBJECTIVE The authors reported the results of surgical procedure of lower limbs varicose (LLV) by stripping and crossectomy of saphenous vein at the National hospital of Niamey. METHODS It is a prospective study during 5 years and half from January 2001 to June 2006. It concerned the all the patients with LLV who underwent a stripping-crossectomy of the(More)
  • 1